About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5881968
Allelic
Composition
Acvr1tm2.1Vlcg/Acvr1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
Tg(tetO-cre)1Jaw/0
Genetic
Background
involves: 129 * 129S4/SvJae * C57BL/6 * C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Acvr1tm2.1Vlcg mutation (0 available); any Acvr1 mutation (43 available)
Gt(ROSA)26Sortm1(rtTA*M2)Jae mutation (32 available); any Gt(ROSA)26Sor mutation (1062 available)
Tg(tetO-cre)1Jaw mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
skeleton
• mice treated with doxycycline at 1 month of age for 3 days then injected with cardiotoxin into the quadriceps muscle to induce inflammation and muscle damage develop large heterotopic ossification tissue masses
• treatment of cardiotoxin-induced muscle injury with palovarotene diminishes heterotopic ossification formation by more than 80%

behavior/neurological
• about 14 days after heterotopic ossification induction by injury in doxycycline treated mice, movement of affected legs is impaired
• treatment with palovarotene of mice with cardiotoxin-induced muscle injury rescues the impaired movement


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/06/2026
MGI 6.24
The Jackson Laboratory